Anthropic is considering an initial public offering at a $2 trillion valuation, according to a report from TheEnergyMag cited in Tuesday market coverage. The figure would place the company behind only a handful of public companies and comes after Anthropic spent $7.3 billion on computing costs, a number that explains why the company needs public-market capital even with deep-pocketed backers.
The report is a single media account, not a company filing, and Anthropic has not commented. But it lands on a day when the company is already at the center of the news cycle: President Trump and House Speaker Mike Johnson are meeting tech CEOs at the White House on September 29 to discuss AI safety, regulation and competition with China, and Anthropic CEO Dario Amodei is among the names circulating in press reports about attendees, though no company has confirmed its participation.
A trillion-dollar IPO on the horizon
The Atlantic profiled the OpenAI-Anthropic rivalry on Monday and described Anthropic as having a trillion-dollar IPO on the horizon, alongside thousands of employees and a public feud with the Pentagon. The $2 trillion figure in Tuesday’s report goes further than that framing. For comparison, Anthropic’s private-market valuation has climbed steeply through successive funding rounds this year, and a listing would be among the largest technology IPOs ever attempted.
The spending side of the ledger is the striking part. $7.3 billion in compute costs in a single period is more than the annual revenue of most S&P 500 software companies. Frontier model training runs have become capital events in their own right, and the gap between what labs spend on compute and what they earn in revenue is the central tension in every frontier lab’s finances. An IPO converts that tension into a public-market question: whether investors will fund the gap at scale, quarter after quarter, with disclosure requirements attached.
It would also mark a turning point for how the AI industry is valued. Private rounds price companies on narrative and benchmark results. Public markets price them on revenue growth, gross margins and cash burn, and they reprice weekly. If Anthropic lists, every subsequent private round at OpenAI, Google DeepMind and the smaller frontier labs will be benchmarked against the public multiple.
The White House meeting
The September 29 summit was first reported by Axios on September 24 and confirmed by Reuters and ABC News. The agenda has not been released, but sources point to industrial strategy, global competitiveness and safety rules for the most advanced models. Johnson had sought the face-to-face for weeks, according to ABC News, and got the green light to put it on the calendar.
The meeting follows weeks of unusual public warnings from AI leaders. Amodei urged a slowdown and warned AI could pose a risk to humanity if handled poorly. Sam Altman and Elon Musk have made similar calls, and Altman and Amodei jointly called for global AI rules at the UN Security Council, receiving a flat no from the United States days earlier. Trump has dismissed the safety warnings as a hoax and rejected global AI governance schemes, arguing that speed is a condition of competing with Beijing. China has introduced binding rules on AI-generated content, algorithms and training data, the opposite end of the spectrum from the US approach.
Behind the summit sits another question: whether the United States ends up with written AI rules or continues relying on voluntary company commitments. Google, OpenAI and Anthropic are working together on a joint safety standards initiative known as SAFA, expected to launch in early 2027. That the industry prefers self-regulation is no secret in Washington, and the White House has so far declined to impose a regulatory brake. The realistic outcomes of the meeting range from a photo opportunity to the start of a legislative push from Johnson, and the White House has released no detailed schedule.
From safety lab to $2 trillion candidate
Anthropic’s founding document, a 2021 Amodei essay titled Vision for a NewCo, envisioned a company of roughly 50 employees built for extreme talent density and predicted building AGI would cost about $10 billion. Five years later the company barely resembles that plan. It has thousands of employees, a high-profile dispute with the Pentagon, which designated it a supply chain risk after defense negotiations collapsed, a move Anthropic has challenged in court, and export-control friction: in June, the Commerce Department ordered Anthropic to prevent foreign nationals from accessing two of its most capable models, Fable 5 and Mythos 5, and the company complied by disabling them for all users three days after their public debut.
Amodei’s safety position has also evolved. The CEO who once framed Anthropic as a small research lab now warns publicly about extinction-level risk, with company researchers citing double-digit probability estimates, while racing OpenAI on enterprise deployments and consumer products. Critics note the tension. Supporters argue the warnings are exactly why the company should be trusted with scale. Either way, the commercial and safety agendas now sit in the same organization at full size, and the feud with OpenAI that The Atlantic chronicled runs through hiring, benchmarks and enterprise deals.
What to watch
Three things matter from here. First, whether the IPO report firms up: an S-1 filing would settle the valuation question, and nothing has been filed. Second, what comes out of the White House meeting, where any joint document is unlikely and separate statements are the more realistic outcome. Third, whether the safety debate keeps fragmenting, with some CEOs calling for a brake and others insisting speed is survival.
The $2 trillion number may prove aspirational. But the direction is clear: the frontier labs are moving from private-market experiments to public companies, and the first major listing will set the terms for the rest. Anthropic, founded as the safety-conscious alternative, is now positioned to be the test case, and the market will get to price its warnings alongside its products.